Levetiracetam Cristers (Levetiracetam)

Levetiracetam exerts its effect by binding to the synaptic vesicle protein SV2A. This binding modulates neurotransmitter release, particularly reducing the release of excitatory glutamate, which lowers neuronal hyper‑excitability and stabilizes abnormal electrical activity that leads to seizures.

The appropriate dose of Levetiracetam Cristers is individualized by the prescribing clinician. Dosage is based on factors such as the patient’s age, weight, renal function, seizure type, and response to therapy. No fixed regimen is provided here; the prescriber sets the exact amount.

Levetiracetam is classified as Pregnancy Category B, indicating that animal studies have not shown risk and there are no adequate human studies. It may be used during pregnancy only if the potential benefit justifies the potential risk. Limited data exist for breastfeeding, so the decision should be made with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After the enquiry, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details (including any cold‑chain requirements) and required import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from many traditional antiepileptics that act on sodium channels or GABA receptors. It generally has fewer drug‑enzyme interactions, a relatively favorable side‑effect profile, and does not require routine therapeutic drug monitoring, making it a convenient option for many patients.

Store Levetiracetam Cristers at temperatures below 25 °C in the original packaging. Protect the tablets from moisture, excessive heat and direct sunlight. Keep the container tightly closed and out of reach of children. No special refrigeration is required for this oral tablet formulation.

Levetiracetam Cristers is taken orally, usually with or without food, as directed by the prescribing clinician. The tablets are swallowed whole with a glass of water. The exact timing and frequency depend on the individualized dosing schedule set by the healthcare provider.

Serious risks include severe allergic reactions such as anaphylaxis, skin conditions like Stevens‑Johnson syndrome, and psychiatric effects including depression, irritability, or suicidal thoughts. Patients should seek immediate medical attention if they notice rash, swelling, breathing difficulties, or significant mood changes.

Levetiracetam is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is advised for patients with severe renal impairment, as dose adjustment may be required. Pregnant or breastfeeding women should only use it when clearly indicated by a healthcare professional.